5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 161.76▼ | 161.83▼ | 161.02▲ | 164.17▼ | 166.12▼ |
MA10 | 161.69▼ | 160.88▲ | 161.13▲ | 166.73▼ | 160.28▲ |
MA20 | 161.96▼ | 161.07▲ | 162.84▼ | 166.45▼ | 154.42▲ |
MA50 | 160.83▲ | 164.28▼ | 165.98▼ | 159.80▲ | 147.09▲ |
MA100 | 161.06▲ | 166.42▼ | 167.10▼ | 155.26▲ | 110.85▲ |
MA200 | 162.45▼ | 167.06▼ | 163.90▼ | 152.50▲ | 84.22▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.077▼ | 0.370▲ | 0.130▲ | -1.331▼ | 0.714▲ |
RSI | 52.297▲ | 47.913▼ | 42.462▼ | 46.674▼ | 54.546▲ |
STOCH | 49.124 | 69.126 | 52.127 | 40.895 | 79.802 |
WILL %R | -64.251 | -34.078 | -32.988 | -76.387▼ | -24.605▲ |
CCI | -36.167 | 75.032 | 80.323 | -120.291▼ | 67.802 |
Tuesday, July 01, 2025 01:05 PM
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced new data that will be presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 161.78 | 162.785 | 161.29 | 161.66 | 189,768 |
02/07/25 | 158.00 | 163.23 | 158.00 | 161.57 | 1,086,939 |
01/07/25 | 166.80 | 167.84 | 159.57 | 160.72 | 1,362,069 |
30/06/25 | 168.41 | 170.145 | 166.815 | 168.94 | 1,058,708 |
27/06/25 | 168.49 | 170.48 | 166.26 | 167.96 | 3,082,537 |
26/06/25 | 166.49 | 168.30 | 163.71 | 168.17 | 1,444,669 |
25/06/25 | 172.82 | 172.82 | 159.4966 | 164.16 | 2,468,407 |
24/06/25 | 171.08 | 172.125 | 167.6397 | 171.87 | 935,449 |
23/06/25 | 170.09 | 173.3873 | 168.935 | 170.37 | 767,225 |
20/06/25 | 171.22 | 173.50 | 169.90 | 171.86 | 1,516,404 |
|
|
||||
|
|
||||
|
|